FDA Approves Xolair as First and Only Medicine for Children and Adults with One or More Food Allergies
Roche has announced that the FDA has approved Xolair® (omalizumab) to mitigate allergic responses, such as anaphylaxis, that may arise from accidental exposure to various foods in both adult and pediatric patients aged 1 year and above with IgE-mediated food allergy. It's emphasized that individuals using Xolair for food allergies must still avoid all allergenic foods. It's also noted that Xolair should not be relied upon for emergency treatment of allergic reactions, including anaphylaxis. IgE-mediated food allergies, which often manifest with swift symptoms upon...
